Year: 2026

Rivaroxaban is an oral anticoagulant (a “blood thinner”) used to reduce the risk of harmful blood clots. It is a prescription drug in the class of direct oral anticoagulants (DOACs), specifically a factor Xa inhibitor. It is commonly encountered in cardiology when preventing stroke in atrial fibrillation or managing venous thromboembolism. Clinicians also consider it in selected patients with atherosclerotic cardiovascular disease when clot-related risk is a concern.

Apixaban is a medication used to reduce harmful blood clot formation. It belongs to the drug category of anticoagulants (often called “blood thinners”). In cardiology, it is commonly encountered when preventing stroke in atrial fibrillation and treating venous thromboembolism. It is taken orally and is part of a group called direct oral anticoagulants (DOACs).

Warfarin is an oral anticoagulant drug that reduces the blood’s ability to form clots. It belongs to the medication class called vitamin K antagonists. It is commonly encountered in cardiology for preventing stroke and systemic embolism. It is also used in patients with certain heart valve conditions and other high-risk thromboembolic settings.

Heparin is an anticoagulant drug that helps prevent blood clots from forming or growing. It belongs to the medication category often called “blood thinners,” though it does not literally thin blood. In cardiology, Heparin is commonly encountered in acute coronary syndrome care, catheter-based procedures, and venous thromboembolism prevention or treatment. It is also used in hospital settings when rapid-onset, adjustable anticoagulation is needed.

Nitroglycerin is a cardiovascular drug used to relieve and prevent angina (ischemic chest discomfort). It belongs to the nitrate class of medications and acts as a vasodilator (it relaxes blood vessels). It is commonly encountered in emergency and inpatient cardiology for chest pain and acute heart failure scenarios. It is also used in outpatient care for patients with stable ischemic heart disease.

Statins are medications that lower blood cholesterol, especially low-density lipoprotein cholesterol (LDL-C). They are a drug class commonly used to reduce atherosclerotic cardiovascular disease risk. They are frequently encountered in cardiology clinics, inpatient coronary care, and preventive medicine visits. They are most often discussed alongside lipid panels, coronary artery disease, and stroke prevention.

Antiplatelet Therapy is the use of medications that reduce platelet activation and aggregation. It is a drug-based strategy aimed at lowering the risk of platelet-rich arterial clots. It is commonly encountered in cardiology after acute coronary syndromes and coronary stent placement. It is also used in broader vascular medicine, including stroke and peripheral artery disease care.

Anticoagulants are medications that reduce the blood’s ability to form clots. They belong to the drug category of “antithrombotic” therapies. In cardiology, they are commonly encountered in atrial fibrillation, venous thromboembolism, mechanical heart valves, and selected acute coronary syndromes. Their central goal is to lower the risk of harmful clot-related events while balancing bleeding risk.

Diuretics are drugs that increase urine production to reduce excess fluid and salt in the body. Diuretics are a medication class commonly used to manage volume overload and blood pressure. Diuretics are frequently encountered in cardiology, especially in heart failure and hypertension care. Diuretics are also used when fluid retention worsens symptoms like shortness of breath or leg swelling.

Calcium Channel Blockers are medications that reduce calcium entry into cells through specific calcium channels. They are a drug class commonly used in cardiovascular medicine. They are frequently encountered in the management of blood pressure, angina, and certain heart rhythm problems. They are also discussed when teaching cardiac electrophysiology and vascular physiology.